The Aroian Group studies human/animal parasitic nematodes as well as bacterial toxins.
Our main goal is to discover new and superior treatments for human soil-transmitted helminths and gastro-intestinal nematodes. In humans, these parasites, aka hookworm, whipworm, and Ascaris (large roundworm) infect upwards of 1.5 billion people in the world and are leading causes of childhood stunting (physical/cognitive), malutrition, adverse preganancy outcomes, loss of productivity... worldwide. For example, when once prevalent in the United States, it is estimated that hookworm-infected US children made 40% less money when they grew up than uninfected peers. These parasites are major causes of poverty worldwide. In addition, the drugs we have now to treat these infections are inadequate to treat some of the parasites and inadequate to eradicate all of them. We are discovering and developing new de-worming (anthelmintic) compounds with superior characteristics to those currently in use and developing novel delivery strategies to make these compounds available widely and cheaply in the developing world. We are also studying how anthelmintic compounds work and how parasite resistance can be overcome.
Similar parasites are widespread in animals and are important disease-causing agents in dogs, sheep, cows, horses, pigs, and poultry. Multi-drug resistant parasites in these animals are present and increasing and new therapies are needed to protect these animals worldwide.
Our work thus encompasses One Health, making both humans and animals healthier worldwide, together.